MD Anderson Delivers a Triple Punch to Pancreatic Cancer
Biospace,
Courtesy of JHVEPhoto/GettyImages A recent study by researchers at the University of Texas MD Anderson Cancer Center found that…
HOXA7 promotes the metastasis of KRAS mutant colorectal cancer by regulating myeloid-derived suppressor cells
Cancer Cell International,
Abstract Background KRAS mutation accounts for 30–50% of human colorectal cancer (CRC) cases.
Syntrix Completes Initial SX-682 Dosing in Broad Phase 1/2 Cancer Trial Campaign Now Encompassing 5 Solid Cancer Types Plus Myelodysplastic Syndromes
ProfitQuotes.com,
AUBURN, Wash., Oct. 27, 2020 /PRNewswire/ -- Syntrix Pharmaceuticals, a clinical-stage biotechnology company developing first-in…